Pharma giant to ‘dispose' of consumer arm in £45bn float
express.co.uk
finance
2022-06-01 21:23:00

Shareholders of the pharmaceuticals giant will vote on the proposed spin-off of the business, which has been christened Haleon, on July 6. It is currently 68:32 owned by GSK and its US rival Pfizer. If the flotation is approved, the British group's stake will drop to 6 percent.While Pfizer will initially retain its stake, it says it plans to offload it entirely.Groups linked to GSK's pension schemes will control around 7 percent of Haleon, while US investment group Blackrock will be the largest outside shareholder, with a 3.
